Itqan Capital has initiated coverage of Mouwasat Medical Services Company (Mouwasat) with an “overweight” rating, setting the stock’s target price at SAR 102.40 per share, the investment firm said in a recent report.

 

Mouwasat is operating according to a clear and strong expansion strategy in the Kingdom’s healthcare sector, which helped sustain revenue growth despite the rise in cost, the report said, pointing that the firm incurred higher costs due to kick starting new projects.

 

Net profit is expected to be impacted by investments, namely Al-Madinah Hospital, Dammam Hospital and a hospital in Yanbu Industrial City, yet a projected relative improvement in Al-Khobar Hospital’s performance will likely offset that impact.

 

Key growth drivers include enhanced healthcare sector in the Kingdom, as well as the company’s expansion strategy and strong financials, Itqan Capital said.

 

Meanwhile, the main risks include the increase in the prices of advanced medical equipment and technology, and the cost of ensuring a qualified medical staff, it added.

Comments 0

Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Market Indices

Created with Highstock 6.0.710:…10:0011:0012:0013:0014:0015:0012,025.0012,050.0012,075.0012,100.0012,125.00
Close : 12097.75 | Jan 9, 15:20

Quotes

Created with Highstock 6.0.710:…10:0011:0012:0013:0014:0015:0012,025.0012,050.0012,075.0012,100.0012,125.00
Close : 12097.75 | Jan 9, 15:20


Call Request

Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.

Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website